Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- PRKS -6.9%, MOS -5.4%, KEEL -5.3%, FSK -3.6%, ORLA -3.1%, TBRG -1.7%, CERT -1.7%, SBH -1.2%
Other news:
- IREN -5.9% (to offer $2 billion aggregate principal amount of convertible senior notes due 2033)
- GMAB -2.3% (Partner Therapeutics announces FDA approval of BIZENGRI (Zenocutuzumab-zbco) for NRG1 fusion-positive cholangiocarcinoma following receipt of FDA Commissioner's National Priority Voucher)
- MBX -2.1% (announces multiple updates on its obesity portfolio)
- OUST -1.6% (files prospectus supplement relating to a sales agreement of its common stock; may offer up to $100 mln of common stock)
- CP -1.2% (CEO Keith Creel statement on UP-NS merger application refiling)
- RKLB -1% (files prospectus supplement, relates to resale by selling stockholders of up to 2,277,002 common shares)
- ONDS -0.9% (files prospectus supplement, relates to offering of 6,351 shares by the selling stockholders)